Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD (X-COPD)
A Multicentre, Randomized-controlled Trial of EXtracorporeal CO2 Removal to Facilitate Early Extubation Compared to Invasive Mechanical Ventilation in Patients with Severe Acute Exacerbation of COPD (X-COPD)
Sponsor: Winicker Norimed GmbH
Terminated
Business decision
Other COPD Exacerbation trials with similar outcome
This NA trial investigates COPD Exacerbation and is currently terminated or withdrawn. Winicker Norimed GmbH leads this study, which shows 11 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Apr 2025 — Sep 2025 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Apr 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Mar 2023 — Mar 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Mar 2023 [monthly]
Not Yet Recruiting NA
-
Jan 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
Sep 2021 — Jan 2022 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2018 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Winicker Norimed GmbH
- Xenios AG
For direct contact, visit the study record on ClinicalTrials.gov .